Harel Insurance Investments & Financial Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $662K | Buy |
1,632
+587
| +56% | +$238K | 0.01% | 194 |
|
|
2025
Q1 | $520K | Buy |
+1,045
| New | +$520K | 0.01% | 191 |
|
|
2022
Q1 | – | Sell |
-102
| Closed | -$68K | – | 809 |
|
|
2021
Q4 | $68K | Hold |
102
| – | – | ﹤0.01% | 550 |
|
|
2021
Q3 | $58K | Sell |
102
-4,205
| -98% | -$2.39M | ﹤0.01% | 523 |
|
|
2021
Q2 | $7.08M | Sell |
4,307
-2,752
| -39% | -$4.53M | 0.16% | 68 |
|
|
2021
Q1 | $10.8M | Buy |
7,059
+1,644
| +30% | +$2.51M | 0.2% | 68 |
|
|
2020
Q4 | $8.11M | Sell |
5,415
-534
| -9% | -$800K | 0.19% | 62 |
|
|
2020
Q3 | $2.63M | Buy |
5,949
+4,107
| +223% | +$1.81M | 0.09% | 72 |
|
|
2020
Q2 | $667K | Buy |
1,842
+233
| +14% | +$84.4K | 0.02% | 103 |
|
|
2020
Q1 | $456K | Sell |
1,609
-158
| -9% | -$44.8K | 0.02% | 105 |
|
|
2019
Q4 | $574K | Sell |
1,767
-108
| -6% | -$35.1K | 0.03% | 115 |
|
|
2019
Q3 | $546K | Buy |
1,875
+341
| +22% | +$99.3K | 0.04% | 100 |
|
|
2019
Q2 | $451K | Buy |
1,534
+1,184
| +338% | +$348K | 0.02% | 123 |
|
|
2019
Q1 | $96K | Buy |
+350
| New | +$96K | 0.01% | 194 |
|
|
2017
Q4 | – | Sell |
-1,700
| Closed | -$322K | – | 509 |
|
|
2017
Q3 | $322K | Hold |
1,700
| – | – | 0.03% | 137 |
|
|
2017
Q2 | $297K | Sell |
1,700
-350
| -17% | -$61.1K | 0.02% | 150 |
|
|
2017
Q1 | $315K | Buy |
+2,050
| New | +$315K | 0.03% | 125 |
|
|
2016
Q3 | – | Sell |
-2,730
| Closed | -$403K | – | 652 |
|
|
2016
Q2 | $403K | Buy |
+2,730
| New | +$403K | 0.05% | 101 |
|